Ensign Peak Advisors’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $682K | Sell |
|
|||||
|
2025
Q1 | $697K | Hold |
|
|||||
|
2024
Q4 | $1.17M | Hold |
|
|||||
|
2024
Q3 | $612K | Hold |
|
|||||
|
2024
Q2 | $670K | Buy |
|
|||||
|
2024
Q1 | $574K | Sell |
|
|||||
|
2023
Q4 | $638K | Sell |
|
|||||
|
2023
Q3 | $911K | Buy |
|
|||||
|
2023
Q2 | $1.44M | Buy |
|
|||||
|
2023
Q1 | $1.77M | Buy |
|
|||||
|
2022
Q4 | $2.12M | Buy |
|
|||||
|
2022
Q3 | $1.87M | Hold |
|
|||||
|
2022
Q2 | $1.71M | Hold |
|
|||||
|
2022
Q1 | $2.04M | Sell |
|
|||||
|
2021
Q4 | $2.38M | Buy |
|
|||||
|
2021
Q3 | $856K | Buy |
|
|||||
|
2021
Q2 | $1.33M | Buy |
|